Total Payments
$2,898
2024 Payments
$1,149
Companies
20
Transactions
139
Medicare Patients
2,705
Medicare Billing
$513,764
Payment Breakdown by Category
Food & Beverage$2,872 (99.1%)
Education$26.00 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,872 | 137 | 99.1% |
| Education | $26.00 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $411.72 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $363.05 | 18 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $349.02 | 18 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $255.13 | 11 | $0 (2024) |
| Travere Therapeutics, Inc. | $247.99 | 11 | $0 (2024) |
| Amgen Inc. | $196.71 | 10 | $0 (2024) |
| Vifor Pharma, Inc. | $189.50 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $163.97 | 10 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $129.16 | 6 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $98.22 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,149 | 61 | Otsuka America Pharmaceutical, Inc. ($153.64) |
| 2023 | $1,234 | 57 | AstraZeneca Pharmaceuticals LP ($255.01) |
| 2022 | $456.40 | 18 | Otsuka America Pharmaceutical, Inc. ($116.63) |
| 2021 | $43.71 | 2 | Amgen Inc. ($27.75) |
| 2017 | $14.46 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14.46) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.30 | General |
| 12/03/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/22/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Airway Clearance Device | ||||||
| 11/13/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Nephrology | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: NEPHROLOGY | ||||||
| 10/09/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $18.65 | General |
| 10/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.81 | General |
| 09/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Nephrology | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Hematology | ||||||
| 09/03/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Nephrology | ||||||
| 08/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Nephrology | ||||||
| 08/15/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 851 | 1,462 | $476,259 | $159,481 |
| 2022 | 13 | 1,196 | 2,109 | $656,001 | $213,913 |
| 2021 | 12 | 658 | 1,103 | $407,953 | $140,371 |
Total Patients
2,705
Total Services
4,674
Medicare Billing
$513,764
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 68 | 160 | $143,040 | $40,765 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 401 | $70,175 | $33,602 | 47.9% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 25 | 72 | $64,368 | $15,785 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 103 | 113 | $42,375 | $14,421 | 34.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 242 | $26,620 | $14,160 | 53.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 135 | $20,250 | $11,810 | 58.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $20,400 | $7,842 | 38.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 29 | $24,012 | $6,182 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 95 | $11,690 | $5,379 | 46.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 43 | 101 | $45,450 | $5,176 | 11.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 23 | $5,694 | $2,719 | 47.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 23 | $2,185 | $1,639 | 75.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 86 | 200 | $178,800 | $51,454 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 180 | 201 | $75,375 | $29,430 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 269 | 419 | $41,900 | $25,175 | 60.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 167 | 440 | $48,400 | $23,620 | 48.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 30 | 106 | $94,764 | $23,297 | 24.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 49 | 63 | $52,164 | $13,544 | 26.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 72 | 168 | $25,200 | $12,855 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 110 | $15,900 | $10,034 | 63.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 60 | 168 | $75,600 | $9,166 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $26,700 | $8,604 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 25 | $5,018 | $2,926 | 58.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 17 | 39 | $6,190 | $2,654 | 42.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Office | 2022 | 11 | 18 | $8,100 | $937.26 | 11.6% |
About Dr. Hamza Arif, M.D
Dr. Hamza Arif, M.D is a Nephrology healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1699161240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hamza Arif, M.D has received a total of $2,898 in payments from pharmaceutical and medical device companies, with $1,149 received in 2024. These payments were reported across 139 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,872).
As a Medicare-enrolled provider, Arif has provided services to 2,705 Medicare beneficiaries, totaling 4,674 services with total Medicare billing of $513,764. Data is available for 3 years (2021–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Owensboro, KY
- Active Since 04/10/2015
- Last Updated 06/14/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1699161240
Products in Payments
- JYNARQUE (Drug) $363.05
- TARPEYO (Drug) $349.02
- FARXIGA (Drug) $279.20
- ACTHAR (Biological) $255.13
- Kerendia (Drug) $163.97
- Veltassa (Drug) $154.96
- TAVNEOS (Drug) $141.69
- LOKELMA (Drug) $132.52
- LUPKYNIS (Drug) $129.16
- ACCRUFER (Drug) $98.22
- IBSRELA (Drug) $89.49
- BENLYSTA (Biological) $57.21
- JARDIANCE (Drug) $56.81
- GORE ACUSEAL Vascular Graft (Device) $53.64
- PURIFIED CORTROPHIN GEL (Drug) $46.93
- Renal - CRRT (Device) $38.89
- Parsabiv (Drug) $27.75
- Aranesp (Biological) $27.27
- Fabhalta (Drug) $22.73
- KRYSTEXXA (Biological) $18.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.